Nyhed
02.04.2025
Skrevet af
Anne-Marie Arnvig

With strong collaboration between researchers, clinical doctors, and patients, the trial data were collected in record time

In September 2024, we reported on our Ph.D. student Kevin Jacobsen, who, in collaboration with forensic geneticists from the Department of Forensic Medicine at the University of Copenhagen, was in the process of designing a series of trials for his study focused on creating less invasive ways to diagnose skin cancer. Now, data from the clinical trials are collected.
Forsker i hudkræft undersøger prøve. Forsker og sygeplejerske pakker prøver.
PhD-student Kevin Jacobsen and project nurse Camilla Kløve Larsen prepares samples for shipment

Scanning and tape

In the trial, the participants' skin changes are scanned with an LC-OCT scanner, which can create images of the skin's upper layers, and a sample is taken with medical tape. The scanner and tape results are checked against biopsies, which are examined for cancer cells, to ensure that the scanner and tape samples have provided the correct answer.

Good collaboration 

Thanks to the good collaboration between the doctors in the dermatology clinic, nurses, researchers, and especially the patients at Bispebjerg Hospital's dermatology department, the team has now collected all the data in record time and is ready for the next steps.

Positive effects of the new methods 

The new diagnostic methods will have several positive effects when they can later be used as a supplement to biopsies:

 - Examination and results in one consultation

 - Fewer biopsies

 - Support for diagnosis and treatment planning

 - Earlier initiation of treatment

Overall, this approach significantly improves the diagnosis of skin cancer and provides patients with a better experience.

Related news